Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 1428-1430, April 1, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, J.-T.
Right arrow Articles by Wang, T.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, J.-T.
Right arrow Articles by Wang, T.-H.

Occurrence of Microsatellite Instability in Gastric Carcinoma Is Associated with Enhanced Expression of erbB-2 Oncoprotein1

Jaw-Town Lin2, Ming-Shiang Wu, Chia-Tung Shun, Wei-Jei Lee, Jin-Chuan Sheu and Teh-Hong Wang

Departments of Internal Medicine [J-T. L., M-S. W., J-C. S., T-H. W. ], Pathology [C-T. S.], and Surgery [W-J. L.], College of Medicine, National Taiwan University, Taipei, Taiwan

To investigate the molecular mechanism of gastric carcinogenesis, we examined simultaneously the frequency of microsatellite instability and the immunoreactivities to ras, erbB-2, and p53 in 42 gastric adenocarcinoma tissues. Microsatellite instability, measured by DNA replication error, was detected in 33.3% (14/42) of patients with gastric carcinoma while positive immunostaining was demonstrated in 3.1% (1/32) for ras, 40.5% (17/42) for erbB-2, and 28.6% (12/42) for p53. There was no statistical difference between the intestinal type and the diffuse type of carcinoma with respect to microsatellite instability, ras, or erbB-2 expression. The expression of p53 occurred more frequently in the intestinal type of carcinoma (41.7%, 10/24) than in the diffuse type of carcinoma (11.1%, 2/18; P < 0.01). There was no association between microsatellite instability and ras or p53 expression, while enhanced expression of erbB-2 occurred more frequently in carcinomas with microsatellite instability (64.3%, 9/14) than in those without microsatellite instability (28.6%, 8/28; P < 0.05). Such a strong association between microsatellite instability and erbB-2 oncogene may be responsible for the increase of other oncogenic mutations and tumor progression in gastric carcinogenesis.

1 This study was supported by Grant DOH-84-TD-010 from the National Science Council and the Department of Health, Executive Yuan, Taiwan, Republic of China.

2 To whom requests for reprints should be addressed, at Department of Internal Medicine, National Taiwan University Hospital, No. 7 Chung-Shan South Road, Taipei, Taiwan.

Received 12/12/94. Accepted 2/14/95.




This article has been cited by other articles:


Home page
Ann OncolHome page
C. Gravalos and A. Jimeno
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
Ann. Onc., September 1, 2008; 19(9): 1523 - 1529.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Yamashita, H. L. Park, M. S. Kim, M. Osada, Y. Tokumaru, H. Inoue, M. Mori, and D. Sidransky
PGP9.5 Methylation in Diffuse-Type Gastric Cancer.
Cancer Res., April 1, 2006; 66(7): 3921 - 3927.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
M. Tanner, M. Hollmen, T. T. Junttila, A. I. Kapanen, S. Tommola, Y. Soini, H. Helin, J. Salo, H. Joensuu, E. Sihvo, et al.
Amplification of HER-2 in gastric carcinoma: association with Topoisomerase II{alpha} gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab
Ann. Onc., February 1, 2005; 16(2): 273 - 278.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. H. Kim, N.-G. Kim, J. G. Lim, C. Park, and H. Kim
Chromosomal Alterations in Paired Gastric Adenomas and Carcinomas
Am. J. Pathol., February 1, 2001; 158(2): 655 - 662.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Oliveira, R. Seruca, M. Seixas, and M. Sobrinho-Simoes
The Clinicopathological Features of Gastric Carcinomas with Microsatellite Instability May Be Mediated by Mutations of Different ""Target Genes"" : A Study of the TGFß RII, IGFII R, and BAX Genes
Am. J. Pathol., October 1, 1998; 153(4): 1211 - 1219.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J D HAYDEN, I G MARTIN, L CAWKWELL, and P QUIRKE
The role of microsatellite instability in gastric carcinoma
Gut, February 1, 1998; 42(2): 300 - 303.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.